Tissue Engineering Heart Valve Leaflets.
组织工程心脏瓣膜小叶。
基本信息
- 批准号:14571284
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Various vascular grafts are commonly used in the reconstruction of cardiovascular tissues. However, currently used prosthetic or bioprosthetic materials lack growth potential and, therefore, subsequently require replacement in pediatric patients as they mature. Tissue engineering (TE) is a new discipline that offers the potential to create replacement structures from autologous cells and biodegradable polymer scaffolds. Because TE constructs contain living cells, they may have the potential to grow, self-repair, and self-remodel. Tissue Engineered Autografts (TEAs) were made by seeding 4-6 x 10^6 of mixed cells obtained from femoral veins of mongrel dogs onto valved patch-shape biodegradable polymer scaffolds composed of a polyglycolic acid (PGA) non-woven fabric sheet and a co-polymer of l-lactide and- caprolactone (N=4). After 7 days, the pulmonary valve leaflet of the same dogs was replaced with TEAs. After 3, 4, 5 and 6 months, angiographies were performed, and the dogs were sacrif … More iced. The implanted TAs were examined both grossly and immunohistologically. The implanted TEAs showed no evidence of stenosis or dilatation. No thrombus was found inside the TEAs, even without any anticoagulation therapy. Remnants of the polymer scaffolds were not observed in all specimens, and the overall gross appearance appeared similar to that of native pulmonary valves. Immunohistological staining revealed the presence of Factor VIII positive nucleated cells at the luminal surface of the TEAs. In addition, lesions were observed where α-smooth muscle actin and desmin positive cells existed. Implanted TEAs contained a sufficient amount of extracellular matrix, and showed neither occlusion nor aneurysmal formation. In addition, endothelial cells were found to line the luminal surface of each TEA. These results strongly suggest that 'ideal' grafts with anti-thrombogenicity can be produced. Because both our laboratory and clinical experiences are quite encouraging, we suggest that the TE approach may play an important role as an alternative method to transplantation and to the use of artificial organs in the field of pediatric cardiovascular surgery. Less
各种血管移植是心血管组织重建的常用方法。然而,目前使用的假体或生物假体材料缺乏生长潜力,因此,在儿童患者中,随着它们的成熟,随后需要更换。组织工程(TE)是一门新的学科,它提供了从自体细胞和可生物降解的聚合物支架中创建替代结构的潜力。由于TE结构含有活细胞,它们可能具有生长、自我修复和自我重塑的潜力。将杂种犬股静脉的4-6 × 10^6个混合细胞植入到聚乙醇酸(PGA)无纺布片和l-丙交酯和-己内酯共聚物(N=4)组成的带瓣片状可生物降解聚合物支架上,制备组织工程自体移植物(TEAs)。7天后,将同一只狗的肺动脉瓣小叶替换为tea。3、4、5和6个月后,分别进行血管造影,并将狗处死。对植入的TAs进行粗观和免疫组织学检查。植入的tea没有狭窄或扩张的迹象。在未进行抗凝治疗的情况下,tea内未发现血栓。所有标本均未观察到聚合物支架的残余,总体大体外观与天然肺瓣膜相似。免疫组织染色显示在tea的管腔表面存在因子VIII阳性有核细胞。此外,在α-平滑肌肌动蛋白和desmin阳性细胞处观察病变。植入的tea含有足量的细胞外基质,未出现闭塞或动脉瘤形成。此外,内皮细胞排列在每个TEA的管腔表面。这些结果强烈表明可以产生具有抗血栓形成性的“理想”移植物。由于我们的实验室和临床经验都非常令人鼓舞,我们建议TE方法可能在儿科心血管外科领域作为移植和人工器官使用的替代方法发挥重要作用。少
项目成果
期刊论文数量(46)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
新岡俊治: "大口径血管の再生医学"ドクターズマガジン. 2003.2. 40-41 (2003)
新冈俊二:“大直径血管的再生医学”,《医生杂志》2003.2(2003)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
新岡俊治, 松村剛毅, 日比野成俊, 内藤祐次, 小坂由道, 黒澤博身: "骨髄細胞を使用する再生血管移植の臨床"日本内科学会誌. 92. 11776-11780 (2003)
Shunji Niioka、Takeki Matsumura、Shigetoshi Hibino、Yuji Naito、Yumichi Kosaka、Hiroshi Kurosawa:“使用骨髓细胞的临床再生血管移植”日本内科学会杂志 92. 11776-11780 (2003)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
A Successful Clinical Application of Tissue Engineered Graft for Extracardiac Fontan Operation
组织工程移植物在心外Fontan手术中的成功临床应用
- DOI:
- 发表时间:2002
- 期刊:
- 影响因子:0
- 作者:Naito Y;Imai Y;Shin'oka T;Aoki M;Kashiwagi;Konuma T;Kurosawa H.
- 通讯作者:Kurosawa H.
小坂由道, 新岡俊治: "生体吸収性人工血管の臨床応用"田畑泰彦編ここまで進んだ再生医療の実際. 96-103 (2003)
Yumichi Kosaka、Shunji Niioka:“生物可吸收人造血管的临床应用”,田端泰彦编辑,迄今为止的再生医学进展96-103。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Effects of dilutional and modified ultrafiltration in plasma endothelin-1 and pulmonary vascular resistance after the fontan procedure
稀释和改良超滤对 Fontan 手术后血浆内皮素-1 和肺血管阻力的影响
- DOI:
- 发表时间:2002
- 期刊:
- 影响因子:0
- 作者:T.Hiramatsu;Y.Imai;H.Kurosawa;Y.Takanashi;M.Aoki;T.Shin'oka
- 通讯作者:T.Shin'oka
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MATSUMURA Goki其他文献
MATSUMURA Goki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MATSUMURA Goki', 18)}}的其他基金
Development of Novel Biodegradable Scaffold for Non-Cell-Seeding In-vivo Tissue-Engineering Vasculature for Clinical Applications
开发用于临床应用的非细胞接种体内组织工程脉管系统的新型可生物降解支架
- 批准号:
23390339 - 财政年份:2011
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of Novel Biodegradable Scaffold for Non-Cell-Seeding In-vivo Tissue-Engineering Vasculature and It's Clinical Applications
非细胞接种体内组织工程脉管系统新型可生物降解支架的研制及其临床应用
- 批准号:
20390373 - 财政年份:2008
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Clinical Application of Tissue Engineered Vascular Autograft using Autologous Bone Marrow Cells and Biodegradable Scaffolds
使用自体骨髓细胞和生物可降解支架进行组织工程自体血管移植的临床应用
- 批准号:
18591563 - 财政年份:2006
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Construction of Tissue-Engineered Vascular Autograft using Bone Marrow Derived Stem Cells and Biodegradable Scaffold and It's Clinical Application
骨髓干细胞和生物可降解支架构建组织工程自体血管及其临床应用
- 批准号:
16591415 - 财政年份:2004
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
TISSUE ENGINEERING PULMONARY ARTERIES
组织工程肺动脉
- 批准号:
12671333 - 财政年份:2000
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Tissue Engineering Hybrid Vessels Using Peripheral Blood Stem Cells and Bioabsorbable Polymer Scaffolds.
使用外周血干细胞和生物可吸收聚合物支架的组织工程混合血管。
- 批准号:
14580834 - 财政年份:2002
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)